45
Participants
Start Date
March 31, 2011
Primary Completion Date
November 30, 2014
Study Completion Date
January 31, 2015
human myeloid progenitor cells
Single intravenous injection/infusion
G-CSF
Background therapy
The Western Pennsylvania Hospital, Pittsburgh
Cleveland Clinic, Cleveland
Indiana Blood and Marrow Transplantation, LLC, Beech Grove
University of Minnesota, Minneapolis
Loyola University Medical Center, Cardinal Bernardin Cancer Center, Maywood
The University of Texas MD Anderson Cancer Center, Houston
Moores UCSD Cancer Center, La Jolla
University of California San Francisco Medical Center, San Francisco
Stanford Hospital and Clinics, Stanford
University of Massachusetts Memorial Medical Center, Worcester
Lead Sponsor
Department of Health and Human Services
FED
Cellerant Therapeutics
INDUSTRY